雷米普利在高危心血管患者中安全性和耐受性的评价

Evaluation of safety and tolerability of Ramipril in high risk patients with cardiovascular events

目的:评价雷米普利10mg在高危心血管患者中安全性和耐受性。方法:研究对象是高危心血管患者,通过观察血压水平和记录患者咳嗽发生次数及其他不利事件,来评价雷米普利10mg在高危心血管患者中的安全性和耐受性。所有的患者均随访2月。结果:患者血压下降及咳嗽发生均无统计学差异。结论:雷米普利10mg在高危心血管患者中是安全的,且耐受性好。

Objective ：To assess the safety and tolerability of ramipril in high risk patients with cardiovascular （CV） events. Methods： Blood pressure （BP） and the incidence of cough or other side effects were observed and recorded. All subjects were followed up for 2 months. Results： There was neither a significant drop in BP, nor a significant increase in the incidence of cough in all patients. Conclusion： The safety and tolerability of ramipril in high risk patients with cardiovascular （CV） events are good.